Replies to post #172507 on Amarin Corp Plc (AMRN)

[biowreck]

Ive felt all along 45-60 for bo. However if i assume 30% market penetration on 20m patients @avg annual script of $2800, and outstanding share count of 330m, then $100 pps would result in 33b bo. That number might be attainable if bp thinks they can ramp up fast, and maximize rev oppty before patent expire